Cite
MLA Citation
Ana Ruiz‐Garcia et al.. “Evaluation of the Relationship of Glasdegib Exposure and Safety End Points in Patients With Refractory Solid Tumors and Hematologic Malignancies.” Journal of clinical pharmacology, vol. 61, 2021, pp. 349–359. http://access.bl.uk/ark:/81055/vdc_100120446045.0x000050